FRAMYXONE, solution ear drops bottle, 10 ml
Active ingredients: Dexamethasone, Framycetin, Dexamethasone sodium phosphate, Framycetin sulfate, Polymyxin b1 sulfate
Commercialized according to BDPMDispensing in France: Prescription only
Solution for instillationbottle, 10 mlauriculaire
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- FRAMYXONE, solution pour instillation auriculaire
- Pharmaceutical form
- solution pour instillation
- Route of administration
- auriculaire
- Presentation description
- 1 flacon(s) polyéthylène basse densité (PEBD) de 10 ml avec compte-gouttes polypropylène
- Marketing authorisation holder
- CILFA DEVELOPPEMENT
- Reimbursement according to BDPM
- 15%
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 19 Sept 1999
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
66586731CIP73415144CIP133400934151446Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| DEXAMÉTHASONEsolution | 0,077 g · 100 ml de solution | FT |
| SULFATE DE FRAMYCÉTINEsolution | — | SA |
| SULFATE DE POLYMYXINE Bsolution | 700 000 UI · 100 ml de solution | SA |
| PHOSPHATE SODIQUE DE DEXAMÉTHASONEsolution | 0,100 g · 100 ml de solution | SA |
| FRAMYCÉTINEsolution | 0,700 g · 100 ml de solution | FT |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.